US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 4.205
  • +0.095+2.31%
Close Aug 8 16:00 ET
  • 4.154
  • -0.051-1.22%
Post 20:02 ET
346.81MMarket Cap-1804P/E (TTM)

Editas Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Editas Medicine Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 7, 2024

Revenue(YoY)

513.00K

-82.23%
EPS(YoY)

-0.82

-46.43%
Analyst Rating

Buy

Aug 8, 2024

Editas Medicine Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 23.914M--
--2024/Q3-- / 1.227M--
Aug 7, 20242024/Q2513.000K / 4.142M--
May 8, 20242024/Q11.135M / 7.296M--
Feb 28, 20242023/Q460.049M / 14.311M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 23.914M--
--2024/Q3-- / 1.227M--
Aug 7, 20242024/Q2513.000K / 4.142M--
May 8, 20242024/Q11.135M / 7.296M--
Feb 28, 20242023/Q460.049M / 14.311M--

Unlock Free Earnings Estimates

Editas Medicine Earnings Reports

  • Editas Medicine | 10-Q: Q2 2024 Earnings Report

    Aug 7 16:17 ET

  • Editas Medicine | 10-Q: Q1 2024 Earnings Report

    May 8 17:04 ET

  • Editas Medicine | 10-K: FY2023 Annual Report

    Feb 28 16:20 ET

  • Editas Medicine | 10-Q: Q3 2023 Earnings Report

    Nov 3, 2023 16:03 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 8, 2024

    Buy

    • Buy

      45.46%

    • Hold

      54.55%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Gene Editing
    Gene Editing
    Intraday+0.91%